Key result
SAMe-TT2R2 score strongly predicts suboptimal TTR after mechanical mitral valve replacement.
Why the study?
This study aimed to evaluate the role of the SAMe-TT2R2 score in predicting anticoagulation control after mechanical mitral valve replacement.
Does the SAMe-TT2R2 score predict Time in Therapeutic Range (TTR) ≥65% in patients after mechanical mitral valve replacement?
Cohort (n=160)
No
Does the SAMe-TT2R2 score predict Time in Therapeutic Range (TTR) ≥65% in patients after mechanical mitral valve replacement?
The SAMe-TT2R2 score can effectively predict the quality of anticoagulation control (TTR) in patients receiving warfarin after mechanical mitral valve replacement.
Answers are grounded in this paper and cite their sources.
May identify patients at risk for suboptimal TTR after mechanical mitral valve replacement; leaves open prospective validation before guiding care.
Background This study aimed to evaluate the role of the SAMe-TT 2 R 2 score in the prediction of anticoagulation control after mechanical mitral valve replacement. Methods and results We retrospectively reviewed clinical data of 160 patients who received mechanical mitral valve replacement at Beijing Anzhen Hospital from January to December 2013. Collected data included the patient's general information and any history of medication, smoking, post-operative embolism due to anticoagulant, bleeding complications, and death information. In the SAMe-TT 2 R 2 score results, the lowest score was 2 points (5.6%), and the highest score was 7 points (0.6%). The number of people with 4 points was the largest (69 people, 43.1%). When the cut-off value of the SAMe-TT 2 R 2 score was set to ≥4, the sensitivity and specificity of predicting Time in Therapeutic Range (TTR) ≥65% were 69.8% and 93.1%, respectively. The Youden index was 0.629. If the cut-off value of the SAMe-TT 2 R 2 score was set to ≤4, the sensitivity and specificity of predicting TTR ≥65% were 93.0% and 44.1%, respectively, and the Youden index was 0.371. The Receiver Operator Characteristic (ROC) curve evaluates the predictive power of the SAMe-TT 2 R 2 score for TTR ≥65%. The figure showed that when the cut-off point was ≥4, the best combination of sensitivity and specificity was shown (69.8% and 93.1%, respectively). The Area Under the Curve (AUC) was 0.854. Conclusions After mechanical mitral valve replacement, the SAMe-TT 2 R 2 model can effectively predict the TTR level during the course of oral warfarin anticoagulation therapy. The SAMe-TT 2 R 2 score ≥4 can predict TTR <65%.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) conducted a cohort in Mechanical mitral valve replacement (n=160). SAMe-TT2R2 score was evaluated on Prediction of Time in Therapeutic Range (TTR) ≥65% (AUC 0.854). The SAMe-TT2R2 score effectively predicted the quality of anticoagulation control after mechanical mitral valve replacement, with a score ≥4 predicting a Time in Therapeutic Range <65%.
Synapse has enriched 10 related papers. Consider them for comparative context: